The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment

计划入组 204 人 · 首次发布于 2023 年 3 月 6 日

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

计划入组 156 人 · 首次发布于 2026 年 4 月 28 日

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

计划入组 200 人 · 首次发布于 2016 年 6 月 17 日

TMP

C₁₀H₁₅N₂O₉P

Tmr

C₂₈H₂₅N₃O₅

MTF-003

TMC Healthcare

United States

TFF Pharmaceuticals

United States

EDAP TMS

France

Tenofovir Amibufenamide Shows Significant Efficacy in Chronic Hepatitis B Patients with Normal ALT Levels

Switching from Entecavir to Tenofovir Alafenamide Shows Similar Efficacy in Chronic Hepatitis B

CRO and Sponsor M&A Disruptions: The Operational Toll on Clinical Trial Sites